Charlotte Guldborg Nyvold
Charlotte Guldborg Nyvold
Verified email at rsyd.dk
Title
Cited by
Cited by
Year
Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome
C Nyvold, HO Madsen, LP Ryder, J Seyfarth, A Svejgaard, N Clausen, ...
Blood, The Journal of the American Society of Hematology 99 (4), 1253-1258, 2002
1752002
Harmonization of BCR-ABL mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories
MC Müller, P Erben, G Saglio, E Gottardi, CG Nyvold, T Schenk, T Ernst, ...
Leukemia 22 (1), 96-102, 2008
972008
Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict …
HB Ommen, CG Nyvold, K Braendstrup, BL Andersen, IB Ommen, ...
British journal of haematology 141 (6), 782-791, 2008
812008
Minimal residual core binding factor AMLs by real time quantitative PCR—Initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood …
J Stentoft, P Hokland, M Østergaard, H Hasle, CG Nyvold
Leukemia research 30 (4), 389-395, 2006
602006
Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance
K Schmiegelow, C Nyvold, J Seyfarth, R Pieters, MMA Rottier, N Knabe, ...
Leukemia 15 (7), 1066-1071, 2001
562001
Molecular typing of adult acute myeloid leukaemia: significance of translocations, tandem duplications, methylation, and selective gene expression profiling
LH Olesen, A Aggerholm, BL Andersen, CG Nyvold, P Guldberg, ...
British journal of haematology 131 (4), 457-467, 2005
432005
h MICL and CD 123 in combination with a CD 45/CD 34/CD 117 backbone–a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia
AS Roug, HØ Larsen, L Nederby, T Just, G Brown, CG Nyvold, ...
British journal of haematology 164 (2), 212-222, 2014
402014
Interleukin-21 mRNA expression during virus infections
C Holm, CG Nyvold, SR Plaudan, AR Thomsen, M Hokland
Cytokine 33 (1), 41-45, 2006
382006
Interleukin-21 mRNA expression during virus infections
C Holm, CG Nyvold, SR Plaudan, AR Thomsen, M Hokland
Cytokine 33 (1), 41-45, 2006
382006
The combined expression of HOXA4 and MEIS1 is an independent prognostic factor in patients with AML
M Zangenberg, L Grubach, A Aggerholm, T Silkjaer, C Juhl‐Christensen, ...
European journal of haematology 83 (5), 439-448, 2009
332009
Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia: Biological and clinical implications
CG Nyvold, J Stentoft, K Brændstrup, D Melsvik, SK Moestrup, ...
Leukemia 20 (11), 2051-2054, 2006
282006
Sensitivity of minimal residual disease in acute myeloid leukaemia in first remission–methodologies in relation to their clinical situation
P Hokland, HB Ommen, CG Nyvold, AS Roug
British journal of haematology 158 (5), 569-580, 2012
262012
Sensitive ligand-based protein quantification using immuno-PCR: a critical review of single-probe and proximity ligation assays
MC Hansen, L Nederby, MOB Henriksen, M Hansen, CG Nyvold
Biotechniques 56 (5), 217-228, 2014
252014
Common variable immunodeficiency unmasked by treatment of immune thrombocytopenic purpura with Rituximab
TH Mogensen, JM Bernth-Jensen, CC Petersen, MS Petersen, C Nyvold, ...
BMC Blood Disorders 13 (1), 1-9, 2013
242013
Characterization and prognostic significance of mitochondrial DNA variations in acute myeloid leukemia
T Silkjaer, JM Nørgaard, A Aggerholm, LH Ebbesen, E Kjeldsen, ...
European journal of haematology 90 (5), 385-396, 2013
242013
Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet
M Østergaard, CG Nyvold, JV Jovanovic, MT Andersen, V Kairisto, ...
Leukemia 25 (7), 1168-1173, 2011
242011
Promoter hypermethylation of the retinoic acid receptor β2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFβMYH11 fusion …
A Rethmeier, A Aggerholm, LH Olesen, C Juhl‐Christensen, CG Nyvold, ...
British journal of haematology 133 (3), 276-283, 2006
232006
Erythropoietin receptor defect: a cause of primary polycythaemia.
KB Petersen, P Hokland, GB Petersen, CG Nyvold
British journal of haematology 125 (4), 537, 2004
212004
Analysis of a Mycoplasma hominis membrane protein, P120
G Christiansen, SL Mathiesen, C Nyvold, S Birkelund
FEMS microbiology letters 121 (1), 121-127, 1994
211994
Delineation and molecular characterization of acute myeloid leukemia patients with coduplication of FLT3 and MLL
LH Olesen, CG Nyvold, A Aggerholm, JM Nørgaard, P Guldberg, ...
European journal of haematology 75 (3), 185-192, 2005
202005
The system can't perform the operation now. Try again later.
Articles 1–20